Asthma, COPD, Cystic Fibrosis Flashcards
FEV1
How much air can be forcefully exhaled in one second
FVC
the maximum volume of air exhaled after taking a deep breath
FEV1/FVC
The % of total air capacity that can be forcefully exhaled in one second
Asthma diagnostic criteria
1.) measure baseline FEV1 with spirometry
2.) give albuterol
3.)Measure post-bronchodilator FEV1
FEV1 increase > 12% = asthma
Asthma guidelines
GINA
Global Initiative for Asthma
NHLBIs Expect Panel Report (EPR)
initial asthma treatment
based on frequency of daytime and nighttime symptoms
Symptoms of Step 1 initial asthma treatment
Day: less than 2x a month
Night: none
PRN low-dose ICS-formoterol or SABA + ICS together
Symptoms of Step 2 initial asthma treatment
Day: more than 2 times a month but less than 4 - 5 days a week
Night: None
Same as step 1 (except SABA taken alone) plus the option of maintenance low-dose ICS
*LTRA or low-dose ICS whenever SABA taken
Symptoms of Step 3 initial asthma treatment
Day: Most days
Night: 1 or more times a week
Same as step 2 but maintenance can also include a low-dose ICS LABA
*low dose-ICS + LTRA or medium dose ICS
Symptoms of Step 4 initial asthma treatment
Day: daily
Night: 1 or more times a week
Same PRN, maintenance is a medium-dose ICS formoterol or medium dose ICS LABA
*High-dose ICS or add on tiotropium or LTRA
Step 5
Same PRN
High dose ICS-formoterol
High dose ICS-LABA
*add tiotropium, oral steroids, or injectable treatments: omalizumab, mepolizumab, reslizumab, and tezepelumab
Well controlled asthma
no daytime symptoms, no awakenings, SABA used less than twice a week, no activity limited
Partially controlled astha
1-2 asthma control questions answered with a yes
-step up 1 step
Uncontrolled asthma
3-4 asthma control questions answered with a yes
-step up 1 to 2 steps
-consider short course of oral steroids
Side effects of Beta-2 agonists
Nervousness, tremor, tachycardia, palpitations, cough, hyperglycemia, decreased potassium
Black Box Warning on LABAs (salmeterol/ formoterol)
increased risk of asthma related deaths
-only used in combination with a ICS
-increased risk of asthma related hospitalization in pediatric and adolescent patients
Brand of beclomethasone
QVAR RediHaler
Brand of Budesonide
Pulmicort Flexhaler
Brand of Budesonide + formoterol
Symbicort
Brand name of fluticasone
Flovent HFA
Flovent Diskus
Arnuity Ellipta
Brane of Fluticasone + Salmeterol
Advair Diskus
Advair HFA
Brand of fluticasone + vilanterol
Breo Ellipta
brand of mometasone
Asmanex HFA
ICS Maintenance Inhalers preferred in Asthma
QVAR RediHaler, Pulmicort Flexhaler, Fluticasone (Flovent HFA, Diskus, and Arnuity Ellipta)
DPIs Name description
Diskus
Ellipta
Press air
HandiHaler
RespiClick
Flexhaler
MDIs Brand identifiers
HFA, Respimat, or no suffix (Symbicort, Dulera)
Shake MDIs prior to use except for which products?
QVAR Redihalr
Alvesco
Respimat products
Order of Use of Inhalers
SABA—> LABA or LAMA —> ICS
*always waiting 60 seconds in between each
MOA of theophylline
blocks phosphodiesterase causing an increase in cAMP and release of EPI from adrenal medulla cells
Result: bronchodilation, diuresis, CNS and cardiac stimulation
Therapeutic range of theophyllin
5 - 15 mcg/mL
*measure peak level at steady state after 3 days or oral dosing
Converting aminophylline to theophylline
multiply by 0.8 or divide by 0.8 to get to aminophylline
That order of kinetics does theophylline follow?
saturable kinetics
-starts as first order then zero order
-small dose increases can result in large increases in concentration
Brand of levalbuterol
Xopenex
*r-isomer of albuterol
Calculating oral loading dose of theophylline
5mg/kg IBW
*or TBW if IBW is less
Maintenance dose = 300 - 600mg daily
Theophylline is a substrate of which enzyme?
CYP1A2
inhibitors:
-Cimetidine
-Ciprofloxacin
-fluvoxamine
-propranolol
-ziluetin
CYP3A4 inhibitors:
-clarithromycin and erythromycin
Others that will increase levels:
-zafirlukast
-alcohol
-allopurinol
-disulfiram
-estrogen-containing oral contraceptives
-methotrexate
Drugs that decrease the level of theophylline
CYP3A4 inducers:
-carbamazepine
-fosphenytoin
-phenobarbital
-phenytoin
-primidone
-rifampin
-ritonavir
-levothyroxine
-st. john’s wort
-smoking
*Also, low carb, high protein diet
What do anticholinergics due in asthma management?
inhibit muscarinic cholinergic receptors and reduce the intrinsic vagal tone of the airway leading to bronchodilation
Simpler terms: cause bronchodilation by blocking the constricting action of acetylcholine at M3 muscarinic receptor in bronchial smooth muscle
short acting anticholinergics
ipratropium
-used in combination with SABAs in hospitalizations
Long acting anticholinergic
(Muscarinic antagonists)
Spiriva Respimat (tiotropium)
-FDA approved in ages 6 or older with history of asthma exacerbations despite ICS/LABA therapy
-Not used alone in asthma! (add on with ICS)
Omalizumab (Xolair)
-monoclonal antibody
-inhibits IgE binding (Receptor on mast and basophil cells)
-for moderate-severe allergic asthma
-6 years and up
-positive skin test to perennial aeroallergen + inadequate control with step 5
Interleukin Receptor Antagonists
-Interleukin = cytokine responsible for eosinophils which are associated with inflammation and the cause of some types of asthma
*Monoclonal antibodies are used to inhibit interleukin from binding to receptors
Monoclonal antibodies that inhibit interleukin
Mepolizumab (Nucala)
-6 and up
Reslizumab (Cinqair)
-boxed warning for anaphylaxis
-adults only
Benralizumab (Fasenra)
-12 and up
-doses every 4 weeks x 3 then every 8 weeks
Dupilumab (Dupixent)
-12 and up every 2 weeks
Emphysema
destruction of the small passages in the lungs (alveoli)
Bronchitis
inflammation and narrowing of the bronchial tubes which results in mucus production and a chronic cough
Alpha-1 antitrypsin (AAT) deficiency
these people are at a higher risk of developing COPD since AAT helps to protect lungs from inflammation
What FEV1/FVC confirms a diagnosis of COPD?
a post bronchodilator FEV1/FVC less than 0.70 confirms a diagnosis of COPD
GOLD 1
Mild severity COPD
FEV1 80% or better
GOLD 2
Moderate COPD
-between 50 and 80% predicted FEV1
GOLD 3
Severe COPD
between 30 and 50% predicted FEV1
GOLD 4
Very severe COPD
FEV1 less than 30% predicted
Does atrovent HFA need to be shaken?
LAMA
-Do not shake
Two commonly used COPD symptom assessment tests
Modified British Medical Research Council (mMRC) dyspnea scale
-asses breathlessness (0-4)
COPD Assessment Test (CAT)
-comprehensive assessment (0-40)
Group A COPD
0-1 moderate exacerbation
-no hospitalization
-CAT less than 10
-mMRC 0-1
Treatment: Bronchodilator
Moderate COPD exacerbation
requires treatment with an oral steroid and possibly an antibiotic
Group B COPD
0-1 moderate exacerbation
-no hospitalizations
-CAT greater than 10
-mMRC greater than 2
Treatment: LAMA+LABA
Group E COPD
2 or more moderate exacerbations
1 or more hospitalization
Treatment: LAMA + LABA
*if blood eosinophil >300 consider LABA + LAMA + ICS
Adverse effects of ICS
-pneumonia
-oral candidiasis
-hoarse voice
Theophylline in COPD
-not recommended unless LABA not available
roflumilast
-phosphodiesterase-4 inhibitor
-used in the most severe patients
C/I: moderate to severe liver impairment
Side effects: diarrhea and weight loss
When should antibiotics be used in COPD?
-increased sputum purulence
-increased sputum volume
-increased dyspnea
-mechanical ventilation required
Atrovent HFA
Ipratropium bromide
-SAMA
MDI: 2 inhalations QID
Combivent Respimat
Ipratropium + albuterol
-SAMA + SABA
MDI: 1 inhalation QID
Tiotropium
Spiriva HandiHaler and Respimat
-LAMA
DPI: requires two puffs
MDI: 2 inhalations daily
Tudorza Pressair
Aclidinium
-LAMA
DPI: 1 inhalation BID
Breztri Aerosphere
Glycopyrrolate + formoterol + budesonide
LAMA + LABA + ICS
Trelegy Ellipta
Umeclidinium (Incruse ellipta)
+ Vilatnerol + Fluticasone
LAMA + LABA + ICS
DPI: 1 inhalation once daily
Formoterol
LABA
Perforomist (nebulizer)
Vilanterol
LABA
-only available in combination products (Breo, Trelegy, Anoro)